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A catalase-based microelectrochemical biosensor developed for real-time neurochemical monitoring of
hydrogen peroxide (H2O2) was characterised in freely-moving rats. The in situ sensitivity of the sensor
was assessed by the direct delivery of H2O2 to the local environment of the implanted sensor and by the
chemical manipulation of the endogenous concentration of H2O2. Inhibitors of H2O2 enzymatic
degradation were utilised including sodium azide (SA) and mercaptosuccinate (MCS). SA and MCS
primarily inhibit catalase and glutathione peroxidase (GPx) respectively and the application of each
resulted in a significant increase in the H2O2 signal. The selectivity of the sensor was verified by the
absence of a change in the signal in response to the peripheral administration of ascorbic acid (AA)
compared to controls. Evidence of a disparity between brain H2O2 signalling in the freely-moving animal
with respect to the anaesthetised subject was also observed. The enzymatic component of the paired
H2O2 sensor was found to be stable over a continuous monitoring period of 12 days, thereby
demonstrating the suitability of this sensor for the long-term chronic detection of brain H2O2.H2O2 is oen considered to be a toxic molecule in the neuronal
environment. Normally, potentially harmful levels of reactive
oxygen species (ROS) such as H2O2 are maintained at an
innocuous level in the brain by the opposing protective anti-
oxidant network. If H2O2 and other ROS are produced beyond
a certain threshold, which exceeds the protective capabilities of
the anti-oxidant network, deleterious processes occur such as
damage to cell structures, DNA, lipids and proteins.1,2
The resulting disruptive state which manifests, due to an
imbalance between ROS production and regulation, is referred
to as oxidative stress. Oxidative stress development has been
implicated in the pathophysiology of neurodegenerative
conditions such as Parkinson's disease and Alzheimer's
disease.3–6 H2O2 is a relatively stable ROS in the neuronal envi-
ronment,7 therefore it possibly represents a suitable marker for
the detection of neurodegenerative disease initiation and
progression mediated by oxidative stress.
Conversely, H2O2 has also recently been shown to play a vital
protective role as an intracellular messenger at normal physio-
logical levels.8–10 It has been reported that H2O2 can modulate
synaptic transmission and neuroplasticity in the rodent brain.9tics Laboratory, Maynooth University,
. Kildare, Ireland. E-mail: Saidhbhe.
tion (ESI) available. See DOI:
hemistry 2017H2O2 has been indicated to act as a neuromodulator via the
modulation of dopamine (DA) release in ex vivo brain slices.11–13
Specically, Rice et al. have demonstrated that endogenous
H2O2 modulates DA release by activation of K+ sensitive aden-
osine triphosphate (ATP) channels in striatal and substantia
nigra neurons.9,11 Indeed, a neuroprotective role for H2O2 has
been proposed in incidences of ischaemic stroke.14
Fluorescent/bioluminescent and MRI-based methods have
been used previously to detect H2O2 in vivo.15–18 However, none
of these reports demonstrate the real-time detection of H2O2 in
the intact living brain and quantitative measurements of brain
H2O2 are not feasible using these methods.
Most brain H2O2 detection methods rely on the use of
microdialysis (MD) which suffers from poor temporal and
spatial resolution.19–21 The estimated basal concentration of
brain H2O2 in rats, determined from MD studies, is between 25
and 50 mM.22 However, the time delay and invasiveness of the
MD technique may have a detrimental impact on the deter-
mined substrate level.21,23,24 Electrochemical methods have an
advantageous distinction in that they provide real-time
measurements of neurochemical species of interest and are
relatively less invasive.25
Kulagina et al. have previously described the electrochemical
detection of H2O2 in the living brain.26 However, these studies
were conducted in anaesthetised subjects and the sensor uti-
lised requires a mediator and an additional method to remove
interference from ascorbic acid (AA); which is not required withAnal. Methods, 2017, 9, 1253–1264 | 1253
Fig. 1 Typical example of the effect of local perfusion (RD) of aCSF, on
the signal recorded from a dual catalase-based H2O2 sensor,
implanted in the striatum of a freely-moving rat. Dashed lines indicate
the duration of perfusion. Inset; average current prior to perfusion
(baseline) and at maximum (P < 0.05* (paired-t) n ¼ 6, 4/4). Pre vs.
post-perfusion baseline (P > 0.05, unpaired-t).
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View Article Onlinethe H2O2 sensor presented here. Sombers et al. have described
the electrochemical detection of brain H2O2 using fast scan
cyclic voltammetry (FSCV) and carbon-ber microelectrodes
(CFE's) in the anaesthetised animal.27,28 However, these publi-
cations do not demonstrate long-term recordings of brain H2O2
as it is an acute non-recovery experimental condition. In addi-
tion the effect of anaesthesia may signicantly impact the
determined basal H2O2 level.29,30
A scarcity of information is thus available surrounding the
basal concentration of brain H2O2 in the freely-moving animal
from electrochemical recordings. Due to recent evidence which
has highlighted the action of H2O2 as a neuromodulator,9 in
addition to the role of H2O2 as an oxidative stress marker,1 the
real-time direct detection of brain H2O2 in the freely-moving
animal would provide a highly novel analytical means of
further understanding its neurochemical role in vivo. A variety
of biosensors such as those that target brain glucose,31,32
glutamate33 and choline34–36 rely on the enzymatic production of
H2O2 at the senor surface. Therefore, an understanding of the
basal concentration of H2O2 in the neuronal environment is an
important consideration with respect to the measurement of
these species in the brain using rst generation biosensors.
We have previously successfully demonstrated the detection
of H2O2 in the in vitro environment with a catalase-based dual
platinum (Pt) electrode design.37,38 This paired H2O2 design
consisted of incorporated permselective layers of poly-o-phe-
nylenediamine (PPD) and Naon® which provided the
optimum sensitivity towards the target substrate and minimal
interference from a variety of endogenous species, including AA
and DA over physiologically relevant concentration ranges.
Moreover, the highly suitable physiological performance factors
of our H2O2 sensor for the purpose brain H2O2 monitoring have
recently been shown, including an appropriately low limit of
detection and fast response time.39
In the present study we report the in vivo characterisation
and validation of this device in freely-moving animals.
Results & discussion
Control experiments
The in vivo characterisation of the dual H2O2 catalase-based
sensor design was achieved by investigating the key perfor-
mance factors of the paired H2O2 sensor under the following
parameters. The response of the sensor to the target analyte, i.e.
H2O2 (sensitivity). The ability of the sensor to reject interference
from endogenous species, i.e. AA (selectivity) and the suitability
of the sensor for the purpose of long term recordings (stability).
The CONTROL sensor acts as a sentinel in vivo and serves to
control for and eliminate any possible contribution from non-
peroxide signals to the overall paired H2O2 sensor response.39
For each in vivo experimental investigation the overall paired
subtracted current response of the H2O2 sensor (IPEROX 
ICONTROL) is presented unless stated otherwise. If a false posi-
tive, was noted at the CONTROL electrode, which would infer
contribution from a non-peroxide signal to the overall dual
H2O2 sensor response, the results from that subject were not
included in the cohort presented here.1254 | Anal. Methods, 2017, 9, 1253–1264All experiments were carried out in the striatum due to the
spatial constraints of the MD probe/dual sensor construct. The
examination of striatal H2O2 changes is also important in terms
of investigating disease mechanisms which largely affect this
area.4,40 The pathological hallmark of Parkinson's disease is DA
cell degeneration in an area of the midbrain known as the
substantia nigra pars compacta (SNc) leading to a loss of striatal
DA.4,40 The inuence of oxidative stress on the degeneration of
neurons in this brain area could be facilitated by monitoring
striatal H2O2 throughout disease progression in an animal
model of the disease.
The vehicle used for all local delivery of chemical/
pharmacological agents, delivered via the reverse micro-
dialysis (RD) method,41 was articial cerebrospinal uid (aCSF).
Therefore, control experiments examined the effect of the local
perfusion of aCSF on the H2O2 sensor response. A typical
example of the observed change in signal is presented in Fig. 1.
Perfusion of aCSF causes compounds present in the tissue
surrounding the MD probe including H2O2, to diffuse across their
concentration gradient through the MD membrane and into the
dialysate. Continuous removal of this dialysate by constant
perfusion of aCSF, maintains the concentration gradient which
leads to a gradual decrease in current detected by the implanted
H2O2 sensor which reaches a minimum plateau level.
On cessation of perfusion, the current gradually returns
towards pre-perfusion baseline levels, as the undisturbed
concentration of H2O2 amongst other analytes, is re-established
in the tissue surrounding the implant.31,42
The local delivery of aCSF through an MD probe, results in
an immediate decrease in current (n ¼ 6, 4/4) recorded by the
paired H2O2 sensor; which is derived by a subtraction method
(see Data acquisition and statistical analysis). A clear change
from a baseline of 0.92  0.16 nA to a plateau minimum of
0.58  0.08 nA (P ¼ 0.0376* (paired-t)) aer 11.3  0.9 min was
observed. A return to a baseline level is apparent aer 30.7 
6.9 min. This corresponds to a H2O2 concentration change of
0.71  0.25 mM based on the in vitro sensitivity of the H2O2
sensor.38,39This journal is © The Royal Society of Chemistry 2017
Fig. 2 Typical example of the effect of peripheral (i.p.) administration
of AA (0.5 mg kg1) and saline (2 mL kg1) on the signal recorded from
a dual H2O2 sensor, implanted in the striatum of a freely moving rat.
Pre vs. post injection baseline (P > 0.05, unpaired-t). Inset; average
maximum current following systemic administration of AA and saline
(P > 0.05 (unpaired-t)).
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View Article OnlineOur paired H2O2 sensor will only respond to a change in
H2O2 levels and not other species present in the extracellular
uid (ECF), as the interference characteristics of the PEROX and
CONTROL sensors are matched and the CONTROL sensor
removes any contribution from non-peroxide sources.37,39 The
overall decrease in response detected by the paired H2O2 sensor
on perfusion of aCSF reects the removal of pre-perfusion
baseline levels of H2O2 from the ECF surrounding the implant
which subsequently returns to a pre-perfusion baseline level
following cessation of perfusion. No signicant difference (P ¼
0.5424 (unpaired-t)) was observed between the pre-perfusion
baseline and the post-perfusion baseline therefore a local
perfusion itself (i.e. aCSF) has no long-term effect beyond
approximately 30 min (30.8  6.9 min) on the H2O2 sensor
response.
A MD probe of 4 mm dialysis membrane length perfused at
2.0 mL min1 has an average approximate analyte in vivo
recovery rate of 45% for the charged species glucose and
lactate.43,44 As H2O2 is uncharged and freely diffusible this gure
may in fact be an under estimation for this substance.22 If we
assume negligible contribution from analyte clearance,
temperature and take into consideration the effect of
membrane length45,46 used here on recovery (i.e. 2 mm) we can
infer an approximate in vivo recovery rate of 22.5%. Similar to
previous investigations,34 based on our recorded concentration
change (0.7 mM) and an estimated recovery rate of 22.5% this
would suggest an estimated basal ECF concentration of 3.1 mM.
This value is somewhat lower than previous estimates from
microdialysis experiments (25–50 mM),22 however upper limits
of intracellular H2O2 concentrations from 100 nM to 1 mM have
been estimated and a level between 15 and 150 mM to facilitate
cellular signalling without oxidative damage has been
proposed.9,14,47Selectivity investigations
The catalase based dual H2O2 sensor is capable of rejecting
interference from a wide range of electroactive species present
in the ECF of the brain.37–39 In order to investigate the selectivity
of the H2O2 sensor in the in vivo environment, the principal
electrochemically active interferent species in the brain, ascor-
bic acid (AA) was diluted in saline systemically administered
and the response of the implanted H2O2 sensor was monitored
(Fig. 2).
There was no signicant difference between the maximum
response of the dual H2O2 biosensor (0.05  0.06 nA max.;
11.4  0.1 min, n ¼ 2, 2/2) following AA administration when
compared to saline (0.07  0.06 nA max.; 11.4  0.1 min, n ¼ 3,
3/3) as a control (Fig. 2, inset). The effect of systemically intro-
duced AA on the ECF concentration of this substance has
previously beenmonitored in vivo using carbon paste electrodes
(CPE's) operating at +250 mV.48 Peripherally administered AA
increases the CPE sensor signal dramatically to a maximum
level approximately 11 min aer injection followed by a gradual
decrease towards pre-injection baseline levels.34,48 Under the
same conditions (Fig. 2) it is clear that the H2O2 sensor is
selective in the physiological environment due to the absence ofThis journal is © The Royal Society of Chemistry 2017the aforementioned amperometric AA signal and a negligible
variation in the H2O2 sensor response.
The individual components of the paired H2O2 sensor i.e. the
PEROX sensor and CONTROL sensor do not show a signicant
difference in signal, in comparison to pre-injection baseline
levels, due to the systemic administration of AA (PEROX, P ¼
0.0566 (paired-t)) and (CONTROL, P ¼ 0.1592 (paired-t)). In
addition, the PEROX sensor signal is well correlated to that of
the CONTROL sensor with no signicant difference (P ¼ 0.4156
(unpaired-t)) observed between the maximum response of these
sensor designs in response to systemically administered AA.
Sensitivity investigations, local delivery of H2O2 (freely-moving
animal)
In order to investigate the sensitivity of the dual H2O2 biosensor
to the target analyte in vivo, a concentration range of H2O2
prepared in aCSF (25, 100, 200, 500 and 1000 mM) was added to
the perfusate in a randomised order (Fig. 3). With respect to
control experiments (aCSF) no signicant change in the sensor
response can be seen on introduction of H2O2 to the perfusate
up to a concentration of 1000 mM (P ¼ 0.4111, one-way ANOVA).
Moreover, for each H2O2 concentration locally introduced to the
sensor no signicant variation (P > 0.05) in the implanted
sensor response was noted with respect to pre-perfusion base-
line levels (see Table 1).
It has been estimated from previous investigations that the
concentration of H2O2 in the brain is between 25 and 50 mM,22
therefore one may expect an increase in the sensor response
upon exposure to a level of H2O2 which exceeds this estimate,
i.e. in excess of 50 mM. However, the data presented in Fig. 3 is
contradictory to this expectation. More specically, although
not signicant (P > 0.05) a small relative increase in the H2O2
sensor response was detected, with respect to the perfusion of
aCSF, following the local addition of 25–1000 mM H2O2 (Fig. 3).
However, as demonstrated by the maximum current change
recorded by the implanted H2O2 sensor (Table 1), following
each addition of H2O2 (25–1000 mM) no signicant increase (P >Anal. Methods, 2017, 9, 1253–1264 | 1255
Fig. 3 The average percentage change from baseline (100%) following
the local perfusion of various dilutions of H2O2 compared with the
local administration of aCSF, as recorded by the H2O2 sensor,
implanted in the striatum of freely-moving Wistar rats (P > 0.05 (one-
way ANOVA) n ¼ 3–6, 3/3–4/4). Pre vs. post-perfusion baseline (P >
0.05, unpaired-t, see Table 1).
Fig. 4 Typical example of the effect of local perfusion (RD) of acet-
aminophen (10 mM), on the signal recorded from PEROX and
CONTROL sensors, implanted in the striatum of a freely-moving rat.
Dashed lines indicate the duration of perfusion. Pre vs. post-perfusion
baseline (P > 0.05, unpaired-t). Inset; average maximum current under
control conditions (aCSF) and following perfusion with acetamino-
phen (P < 0.0001***, one-way ANOVA, n ¼ 3, 3/3).
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View Article Online0.05) above pre-perfusion baseline level was recorded during the
perfusion of each concentration of H2O2. In fact, a decrease was
recorded by the implanted H2O2 sensor in each case following
the local addition of the substrate (25–1000 mMH2O2). This was
an unexpected response given that the concentration of
substrate added to the perfusate should closely match or exceed
the previously estimated ECF concentration of endogenous
brain H2O2 (25–50 mM) and therefore lead to no obvious change
in current or an increase in current respectively, as recorded by
the implanted sensor.
In order to unequivocally demonstrate that the H2O2 sensor
is functional while implanted in brain tissue an electroactive
challenge was undertaken. Acetaminophen (paracetamol),
a known electroactive species49,50 with can be oxidized at
a similar potential to H2O2 was delivered to implanted PEROX
and CONTROL sensors in the same manner as H2O2. As can be
seen in Fig. 4 the local delivery of paracetamol (10 mM)
through an MD probe, results in an immediate increase in
current recorded by PEROX and CONTROL sensors (n¼ 3, 3/3),
to a plateau maximum of 43.13  11.77 nA (PEROX) and 16.09
 3.08 (CONTROL), (P¼ 0.0895, unpaired-t) aer 9.2 2.5 min
(PEROX) and 12.7  1.3 min (CONTROL), (P ¼ 0.2837,
unpaired-t) with a return to a pre-perfusion baseline levelTable 1 Summary of paired H2O2 sensor results obtained following additi
200, 500 and 1000 mM) to the perfusate in freely-moving animals (data
Analyte
Max current
change (nA)
Max
response (min)
Return to
baseline (min)
Pre-pe
baseli
aCSF 0.34  0.12 11.3  0.9 30.8  6.9 0.92 
25 mM H2O2 0.28  0.09 10.2  1.2 44.4  4.1 0.93 
100 mM H2O2 0.15  0.11 10.5  0.5 26.2  2.4 0.73 
200 mM H2O2 0.21  0.09 12.3  0.2 37.0  2.1 1.62 
500 mM H2O2 0.07  0.04 11.3  0.7 68.9  27.4 0.91 
1000 mM H2O2 0.09  0.04 12.2  0.2 39.2  9.8 0.83 
1256 | Anal. Methods, 2017, 9, 1253–126448.6  0.6 min (PEROX) and 42.1  5.6 min (CONTROL), (P ¼
0.3065, unpaired-t) subsequently.
The maximum response recorded here (Fig. 4) following
perfusion of 10mM paracetamol is signicantly different to that
seen on perfusion of aCSF when compared against each sensor
type (P < 0.0001***, one-way ANOVA) Fig. 4, inset. Therefore, the
implanted electrochemical sensor responds to an electroactive
challenge and is functional in brain tissue.
The limit of detection of our PEROX sensor is below 1 mM
(ref. 38 and 39) indicating that our PEROX sensor can reliably
detect low levels of H2O2 which is expected to be the case in the
brain.7 Our sensor demonstrates a characteristic fast response
time in vitro,39 therefore the detection of this potentially short
lived species in the brain should be facilitated.
It has previously been demonstrated, that redox reactions of
various electroactive species in vitromay depend on the aqueous
media conditions utilised to facilitate experiments. A variation
in the sensitivity of carbon ber electrodes to DA and related
metabolites has been demonstrated in vitro between different
aqueous media including HEPES-buffered saline, PBS and
aCSF.51,52
In our experiments any possible detrimental impact the
composition of aCSF has on the viability of H2O2 delivered toon of aCSF and various concentrations of H2O2 diluted in aCSF (25, 100,
pertaining to Fig. 3). P ¼ unpaired-t-test
rfusion
ne (nA)
Post-perfusion
baseline (nA) n
P, max vs.
control (aCSF)
P, pre vs. post-
perfusion baseline
0.16 0.78  0.14 6, 4/4 n/a 0.5424
0.18 0.84  0.17 4, 3/3 0.7585 0.7207
0.22 0.63  0.15 3, 3/3 0.3666 0.7234
0.42 1.42  0.37 4, 3/3 0.4611 0.7425
0.16 0.93  0.18 3, 3/3 0.1745 0.9478
0.12 0.78  0.12 3, 3/3 0.2109 0.7927
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinethe striatum using this vehicle has been excluded based on in
vitro investigations (data not shown).38
The delivery of H2O2 to the implanted catalase-based H2O2
sensor may be restricted by recovery issues associated with the
MD/RD technique.34,41 Under maximal conditions where a slow
ow rate and relatively long MD membrane are utilised the
recovery ratio has been estimated to be only 70%.53 Therefore,
with the RD technique not all of the substrate added to the
perfusate will reach the tissue surrounding the implanted
sensor (potentially as low as 30%). Thus this inherent recovery
issue may result in a lower than expected recorded response by
the implanted sensor.
However, even with recovery ratio restrictions the highest
concentration of H2O2 delivered to the implanted dual sensor in
these experiments i.e. 1000 mM should vastly exceed the ECF
concentration which is estimated to exist at a much lower range
(25–50 mM).22
The absence of an increase detected by the implanted dual
H2O2 sensor above pre-perfusion baseline levels (Fig. 3) may
then be due to the effect of an inherent mechanism of the in vivo
environment. It is well understood that an intricate network of
neuronal antioxidant mechanisms exist to regulate the level of
H2O2/ROS in the brain. Homeostasis of the balance between
ROS concentration and peroxidase activity in the brain is
essential and must be maintained to prevent oxidative damage
and thus maintain cellular integrity.9,54,55
It is possible that any effect of the local addition of H2O2 on
the ECF concentration of this substrate is dampened by this vast
network of control mechanisms. Our experiments indicate that
the effect of local addition of H2O2, of a concentration higher
than that estimated to be present in the ECF, can be negated by
the action of the opposing antioxidant network.
To the best of our knowledge, this is the rst time the effect
of exogenous application of H2O2 on the ECF level of this
substrate has been examined using electrochemical methods in
the freely-moving animal. Previous research has highlighted
a detectable response by an implanted electrochemical H2O2
sensor in response to the local addition of H2O2, however this
research was conducted in the anaesthetised animal and
a relatively higher concentration of H2O2 was utilised (1 M).28
Our data provides novel evidence, which would support
previous assumptions, that the robust neuronal antioxidant
network in the freely moving subject can tolerate the presence
of a relatively high concentration of H2O2.Fig. 5 Typical examples of the effect of various treatments, on the
signal recorded fromH2O2 sensors, implanted in the striatumof freely-
moving rats. Top; Local perfusion of 1000 mM H2O2 under control
conditions (no pre-treatment). Pre vs. post-perfusion baseline (P >
0.05, unpaired-t). Middle; 1000 mM H2O2 local perfusion following
peripheral injection of the catalase inhibitor SA (20mg kg1 s.c.). Pre vs.
post-perfusion baseline (P > 0.05, unpaired-t). Bottom; Average
maximum current following perfusion of 1000 mMH2O2 under control
conditions and at maximum following pre-treatment with SA (P <
0.05* (unpaired-t) n ¼ 3, 3/3).Altered enzymatic degradation, catalase inhibition (sodium
azide)
As previously discussed a vast network of antioxidant mecha-
nisms regulate the level of H2O2/ROS in the brain.9,54,55 Chief
among these opposing antioxidant systems are the peroxidase
enzymes which consist primarily of catalase and glutathione
peroxidase (GPx).9,56 Systemic administration of sodium azide
(SA) has previously been used in in vivo experiments and
inhibits the function of catalase in the brain.57–59
As catalase is an enzyme which degrades H2O2 into water and
oxygen, impairment in the activity of catalase in the brainThis journal is © The Royal Society of Chemistry 2017should lead to an increase in H2O2 levels. In this experiment
(Fig. 5, middle), SA was administered to each subject (20 mg
kg1 s.c.) approximately 30 minutes prior to the local admin-
istration of 1000 mM H2O2 to examine the effect of catalase
inhibition on the subsequent local delivery of H2O2 to the
implanted sensor.
In the absence of pre-treatment with SA the local addition of
1000 mM H2O2 (Fig. 5, top) does not impact upon the H2O2
sensor response (n ¼ 3, 3/3). No signicant difference wasAnal. Methods, 2017, 9, 1253–1264 | 1257
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View Article Onlineobserved between the pre-perfusion baseline 0.83 0.12 nA and
the maximum deviation in the sensor signal (Fig. 4, top; 0.74 
0.11 nA, P ¼ 0.1614 (paired-t)).
In contrast to the previous nding (Fig. 4, top) pre-treatment
with SA (20 mg kg1 s.c.) leads to a marked increase in
response detected by the implanted sensor in response to the
local addition of 1000 mMH2O2. As can be seen in Fig. 5 (middle)
following pre-treatment with SA; the local delivery of H2O2
through an MD probe, results in an immediate increase in
current (n ¼ 3, 3/3) recorded by the H2O2 sensor, from a baseline
of 0.8 0.44 nA to a plateau maximum of 1.07 0.35 nA aer 3.3
 1.2 min with a return to a pre-perfusion baseline level 31.2 
3.4 min subsequently. The maximum response recorded here
(Fig. 4, middle) following perfusion of 1000 mM H2O2 with SA
pretreatment is signicantly different to that seen in the absence
of SA pre-treatment (P ¼ 0.0238* (unpaired-t) Fig. 5, bottom).
SA has other in vivo targets in addition to catalase, e.g.
cytochrome oxidase, which may inuence ROS control and
production.59 However, the effect of SA pre-treatment on the
H2O2 sensor response (0.02  0.04 nA; 7.6  5.2 min, n¼ 3, 3/3)
before the perfusion of H2O2 itself (30 min prior) is minimal,
not signicantly different to pre-injection baseline levels (P ¼
0.7565 (paired-t)) and not signicantly different (P ¼ 0.5396
(unpaired-t)) in comparison to the negligible effect (P ¼ 0.3904
(paired-t)) of saline injection (0.07  0.06 nA max.; 7.2 
0.3 min, n ¼ 3, 3/3).
This SA pre-treatment and subsequent H2O2 administration
paradigm does not affect the response of the CONTROL sensor
itself, i.e. the catalase adhered to the active surface of this
electrode design. No signicant difference (P ¼ 0.8835 (paired-
t)) was observed between the pre-perfusion baseline (1.60 0.52
nA n ¼ 3, 3/3) of the CONTROL sensor in comparison to the
maximum deviation (1.56 0.33 nA n¼ 3, 3/3) in the CONTROL
sensor signal recorded throughout the perfusion of 1000 mM
H2O2 following SA pre-treatment, thus eliminating any possible
non-peroxide contribution to the H2O2 sensor signal.
It is quite clear from the evidence presented in Fig. 5 that
catalase inhibition via the peripheral administration of SA,
prior to the local addition of this concentration of H2O2, is
sufficient to elevate the ECF concentration of this substrate and
thus lead to an increase in response detected by the H2O2
sensor.Fig. 6 Typical example of the effect of local perfusion of the GPx
inhibitor MCS; (1000 mM), on the signal recorded from a H2O2 sensor,
implanted in the striatum of a freely moving rat. Inset; average current
prior to perfusion (baseline) and at maximum (P < 0.05*, (paired-t) n ¼
3, 2/2). Pre vs. post-perfusion baseline (P > 0.05, unpaired-t).Local delivery of mercaptosuccinate (glutathione peroxidase
inhibition)
Mercaptosuccinate (MCS) is a glutathione peroxidase (GPx)
inhibitor which has previously been implemented to elevate the
concentration of H2O2 in cultured brain cells.60 Glutathione
redox homeostasis maintains the primary anti-oxidant defence
systems in the central nervous system and GPx is the primary
enzyme responsible for degradation of neuronal ROS/H2O2.56
Disruption to the function of GPx in the brain of the freely-
moving animal should therefore lead to increased neuronal
H2O2 production as seen previously.11,28 In addition, while MCS
is an electroactive species it is not detectable by the H2O2
sensor.391258 | Anal. Methods, 2017, 9, 1253–1264The local perfusion of MCS will disrupt H2O2 removal and
hence lead to an increase in H2O2 levels in the brain and
consequently an elevated concentration of H2O2 in the ECF
surrounding the implanted sensor. Indeed, it has previously
been demonstrated that exposure of ex vivo brain slices to 1–
100 mMMCS is sufficient to inhibit GPx and lead to an elevated
level of neuronal H2O2 and this parameter has also been
determined by voltammetric methods in anaesthetised rodents
using CFE's.9,28
The local addition of 1000 mM MCS (n ¼ 3, 2/2) to the
implanted sensor was sufficient to induce an elevation in
endogenous H2O2 levels as indicated by the clear increase
recorded by the dual catalase-based H2O2 biosensor (Fig. 6). A
signicant difference was observed between the pre-perfusion
baseline (1.35  0.25 nA) and the maximum change in the
H2O2 sensor signal (1.65  0.31 nA, P ¼ 0.0414* (paired-t))
which represents a maximum change of 0.30  0.06 nA occur-
ring 7.1  1.3 min from the start of the perfusion and which
returned to pre-perfusion baseline levels 42.2  9.7 min
following cessation of the local delivery of MCS. Moreover, no
signicant difference (P ¼ 0.9001 (paired-t)) was observed
between the pre-perfusion baseline (0.74 0.14 nA n¼ 3, 2/2) of
the CONTROL sensor in comparison to the maximum deviation
(0.76  0.24 nA n ¼ 3, 2/2) in the CONTROL sensor signal,
thereby eliminating any non-peroxide contribution to the H2O2
sensor signal.
It is clear that altered enzymatic degradation via disruption
to the function of catalase and GPx is necessary to increase ECF
levels of H2O2. By manipulation of endogenous H2O2 levels we
have been able to detect a change in the level of this substance
in the brain using our implanted H2O2 sensor in the freely-
moving animal (Fig. 5 and 6).
This collective real-time data suggests and lends support to
previous ndings that neuronal H2O2 levels are tightly
controlled under normal circumstances.5,55 We suggest that in
conditions of disease states where antioxidant and controlling
mechanisms are compromised H2O2 levels are relativelyThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineelevated as evidenced by the result of manipulating enzymatic
degradation of brain H2O2.Fig. 7 Typical examples of the effect of various treatments, on the
signal recorded from paired H2O2 sensors, implanted in the striatum of
anaesthetised rats. Top; Local perfusion of aCSF. Pre vs. post-perfu-
sion baseline (P > 0.05, unpaired-t). Middle; Local perfusion of 10 mM
H2O2. Pre vs. post-perfusion baseline (P > 0.05, unpaired-t). Bottom;
Average maximum current following perfusion of a CSF n ¼ 4, 4/4
compared against maximum following 10 mM H2O2 administration n
¼ 4, 3/3 (P < 0.05*, unpaired-t).Local delivery of H2O2 (anaesthetised animal)
In light of the previous evidence and existing research, we
decided to investigate circumstances where the level of H2O2
locally introduced greatly exceeds estimated physiological
levels of this substance in the ECF.14,22,47 The maximum
concentration that had been tested in the freely-moving animal
(i.e. 1000 mM, Fig. 5, top) was not sufficient to cause an increase
in the H2O2 sensor response. Moreover, when a similar range
was tested (50–1000 mM H2O2) in the acute setting a relative
increase in the paired sensor response was observed, but
a variation at the CONTROL sensor was consistent throughout
(data not shown).38 To induce a meaningful increase at the
PEROX sensor in the absence of a change at the CONTROL
sensor, it was deemed necessary to introduce a much higher
concentration of H2O2. In order to introduce a relatively higher
and potentially toxic concentration of H2O2 (10 mM), while
avoiding potential complications and/or adverse or detri-
mental effects to the freely-moving awake animal, we used
anaesthetised animals and carried out an acute non-recovery
experimental protocol.
The local perfusion of aCSF in the acute preparation (Fig. 7,
top) results in a decrease in current (0.05  0.02 n¼ 4, 4/4; 6.9
 1.6 min) detected by the implanted dual H2O2 sensor which is
similar to the trend observed in the freely-moving animal where
a decrease in sensor signal is apparent due to the aforemen-
tioned reasons (Fig. 1). This recorded value (Fig. 7, top) corre-
sponds to a calculated concentration change of 0.10  0.04 mM
based on the in vitro sensitivity of the H2O2 sensor.38 Using our
estimated in vivo recovery rate (22.5%) the approximate basal
concentration of brain H2O2 in the anaesthetised animal is 0.44
mM. This value is lower than that observed in the freely-moving
scenario where an estimated ECF concentration of 3.1 mM was
determined. The disparity in basal H2O2 levels in the brain
observed between the acute and freely-moving setting may be
attributable to the effect of anaesthesia.29
In the acute preparation a relatively high concentration of
H2O2 diluted in aCSF was required to induce a substantial
change at the peroxide sensing element of this paired design
(10 mM, see Fig. 7). A large increase in target substrate
concentration was detected by the implanted dual H2O2 sensor
(Fig. 7, middle). Exogenous application of 10 mM through the
MD probe in the acute preparation (Fig. 7, middle), results in an
immediate increase in response (0.77 0.33 nA n¼ 4, 3/3; 9.3
1.4 min) detected by the implanted dual H2O2 sensor. The
maximum change in current observed following the adminis-
tration of 10 mM H2O2 was signicantly different to that
observed upon perfusion of aCSF (Fig. 7, top) in the acute
preparation (P ¼ 0.0499* (unpaired-t); Fig. 7, bottom).
This evidence supports previous investigations conducted in
the acute preparation, which have demonstrated an increase in
H2O2 levels following local addition at a level which greatly
exceeds the estimated ECF concentration of this substrate.28
The evidence presented in Fig. 7 demonstrates clearly that ourThis journal is © The Royal Society of Chemistry 2017H2O2 sensor responds to an induced change in the target
substrate in the neuronal environment.
A contrasting H2O2 response was observed here in compar-
ison to that observed in the freely-moving scenario. A clear
increase above baseline levels of H2O2 was detected by the H2O2
sensor following perfusion of 10 mM H2O2 in the acute exper-
imental set-up (Fig. 7, middle). Although a higher concentration
was applied in the acute scenario (i.e. 10 mM) the disparity in
the results between the acute and freely-moving animal data
(Fig. 3) may also be inuenced by the constant use of anaes-
thetic in the acute procedure (see below).Anal. Methods, 2017, 9, 1253–1264 | 1259
Fig. 8 Average baseline in vivo data for a consecutive period of 12
days following implantation (P > 0.05, one-way ANOVA), collected
from a cohort of 7 animals. Data was recorded by catalase modified
sensors implanted in the striatum of freely moving rats.
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View Article OnlineA disparity between the average baseline current of the H2O2
sensor was apparent in the acute preparation (0.27  0.04 nA,
n ¼ 3, 3/3) when compared to the freely-moving scenario 1.97 
0.23 nA, n ¼ 5, 5/5 (P ¼ 0.0003*** (unpaired-t)). In the anaes-
thetised animal the pre-perfusion baseline of the CONTROL
and PEROX sensor are in very close proximity to each other and
share similar baseline current values which explains the nega-
tive paired baseline response of the dual catalase-based H2O2
sensor (0.27  0.04 nA, n ¼ 3, 3/3). This observation contrasts
with that observed in the freely-moving animal, where the
baseline of the PEROX sensor is higher than the CONTROL
sensor in the freely-moving animal thereby resulting in a posi-
tive average subtracted value (1.97  0.23 nA, n ¼ 5, 5/5).
A relatively limited amount of time is available to conduct
an acute experiment due to the nature of the experimental
conditions. It is possible that in the acute set-up the capaci-
tance of the H2O2 sensor does not have sufficient time to
dissipate which may inuence the calculated baseline. This
parameter was investigated by calculating the average time
facilitated between the application of the potential to the
implanted sensor prior to commencement of perfusions in the
acute preparation (100.7  11.9 min, n ¼ 3, 3/3) and calcu-
lating a new average baseline from freely-moving H2O2 data at
the same time point. A discrepancy in baseline levels between
the acute and freely-moving preparations was still apparent
following a similar time-frame (100 min, n ¼ 5, 5/5) from the
application of the potential to the working electrodes (P ¼
0.0487* (unpaired-t)).
Anaesthesia has been shown to cause an alteration of various
mechanisms and levels of neurotransmitters in the central
nervous system (CNS).29,30,61 A limited amount of information
exists surrounding the effect of volatile anaesthetics such as
isourane on electroactive species such as H2O2 in the brain.
Anaesthesia may inuence the function of the antioxidant
network in the brain. In which case exogenously applied H2O2
may not be efficiently removed resulting in an increased
response detected by the implanted H2O2 sensor. Anaesthesia
causes systemic CNS depression and hence a decrease in
neuronal activity.61 The production of H2O2 is linked to
increased neuronal activity due to an increased level of O2
consumption which generates H2O2.9 The effect of anaesthesia
may therefore explain the reduction between the estimated
basal concentration of brain H2O2 determined in the freely-
moving animal (3.1 mM) when compared to the acute scenario
(0.44 mM).Stability investigations
A decrease in the sensitivity of a biosensor can oen be
observed following contact with a biological sample. Typically
a variable 20–50% decrease may occur following implantation
due predominantly to fouling of the sensor by proteins and
other biomolecules present within the tissue.33,35 The normal
reaction of the body to the presence of a foreign object may also
negatively affect the sensitivity of an implanted sensor.
However, the brain is an immunoprivileged organ to an
extent62,63 and immune reactions are relatively suppressed in1260 | Anal. Methods, 2017, 9, 1253–1264comparison to the periphery and long-term implants are rela-
tively more tolerated.
The mean baseline current of the enzymatic component of
the H2O2 sensor i.e. the catalase based sensor (CONTROL) was
examined over a consecutive period of twelve days in the freely-
moving animal (Fig. 8). Recordings were taken following an
initial period of ca. 24 h recovery from surgery and an additional
24 h following the application of the potential to the sensors (i.e.
48 h following implantation). This process effectively eliminates
non-faradaic capacitance contributions to the sensor signal and
contributions from disruption to the blood brain barrier and
other immediate disturbances to the tissue in the initial period
following implantation.
Each baseline value was calculated from the same one hour
period (5–6 am) prior to commencement of experimental
procedures for each day of implantation. A one-way ANOVA
analysis of variance revealed that the baseline current showed
no signicant variation (P ¼ 0.9185) over the stated duration of
implantation. These results verify the stability of this sensor for
the purpose of obtaining long-term in vivo electrochemical
recordings.Conclusions
Signicant signal changes were observed at the H2O2 sensor
following the local administration of aCSF and MCS. Catalase
inhibition via pre-treatment with SA facilitated an increase in
the response of the H2O2 sensor following the exogenous
application of 1000 mM H2O2 in the freely-moving animal. The
local administration of 10 mM H2O2 under anaesthesia led to
an immediate increase in response detected by the catalase-
based dual H2O2 sensor. Such results conrm the sensitivity
of the H2O2 sensor to the target substrate in the neuronal
environment. No interference was observed in the sensor
response upon administration of high levels of AA in the in vivo
environment. Moreover, the response of the enzymatic
component of the dual H2O2 sensor design remained stable
over a continuous period of 12 days.This journal is © The Royal Society of Chemistry 2017
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View Article OnlineThe local application of H2O2 up to a concentration of 1000
mM in the freely-moving scenario was not sufficient to elevate
brain H2O2 levels, as determined by the lack of a change in
response of the implanted H2O2 sensor. Our research suggests
that inherent controlling mechanisms of the neuronal envi-
ronment are sufficient to handle the exogenous application of
H2O2 within the range tested here in the freely-moving animal.
The highly effective anti-oxidant network present in the brain
serves as a mop-up mechanism which removes potentially
harmful reactive oxygen species such as H2O2. The results out-
lined here, lend support to the hypothesis that brain H2O2 is
tightly controlled by the anti-oxidant network in situ.1,5,55
Brain H2O2 concentration estimates determined using our
electrochemical methods in the anaesthetised animal (0.44 mM)
and in the freely-moving scenario (3.1 mM) demonstrate
a disparity in the baseline level of this substance. A decrease in
neuronal activity corresponds to a decreased demand for
regional cerebral blood ow and hence a matched reduction in
oxygen levels.64 Under anaesthesia the decreased demand for
and consumption of O2 is due to an induced drop in neuronal
activity.61 This process should reect a relative change in brain
H2O2 production as H2O2 is derived indirectly from the mito-
chondrial reduction of O2.9 Our research also questions the
ability of the antioxidant network to suppress the effect of
exogenous application of H2O2 under conditions of anaesthesia
in the acute preparation.
As previously discussed, a variety of rst generation biosen-
sors rely on the enzymatic production of H2O2 at the active
surface of the sensor.33–36 Local perfusion data presented here
indicates that endogenous H2O2 is tightly regulated under
normal circumstances. Indeed, the estimated basal concentra-
tion of brain H2O2 in the freely-moving animal (3.1 mM) is quite
low with respect to previous estimates.22 Therefore, endogenous
H2O2 is unlikely to be an interferent for rst generation
biosensors in terms of neurochemical monitoring. However,
such interference would need to be validated for each device
given the variety of electrode types, surface modications and
enzyme immobilisation techniques used.
The main performance factors of the H2O2 sensor i.e.
sensitivity, selectivity and stability have been veried in the in
vivo environment. Therefore, the real-time detection of H2O2 in
normal cellular signalling and as an oxidative stress marker in
neurodegenerative conditions such as Parkinson's disease, may
be facilitated by using this H2O2 sensor design.
Methods
Chemical and solutions
All chemicals used were of analytical reagent grade or higher
quality and purchased from Sigma Chemical Co. (Dublin, Ire-
land). All in vitro experiments were conducted in phosphate
buffered saline (PBS), pH 7.4; NaCl (0.15 M), NaOH (0.04 M) and
NaH2PO4 (0.04 M) which was prepared in doubly distilled
deionised water (ddH2O). Local in vivo administrations of
a range of H2O2 concentrations (25, 100, 200, 500, 1000 mM and
10 mM), mercaptosuccinate (MCS, 1000 mM) and acetamino-
phen (10 mM) were prepared in articial cerebrospinal uidThis journal is © The Royal Society of Chemistry 2017(aCSF) which contained NaCl (0.15 M), KCl (0.004 M), CaCl2
(0.0016 M) and MgCl2 (0.021 M) made up in ddH2O. For
systemic administrations sodium azide (SA, 20 mg kg1)58 and
(AA, 0.5 mg kg1) were prepared in normal saline (0.9%) and
administered by peripheral injection, subcutaneous (s.c.) and
intraperitoneal (i.p.) injection respectively, at a volume of 2 mL
kg1. The chosen administered dose of both AA and SA was
based on previous investigations34,58,59,65 and had no adverse
effect on the animal.
H2O2 sensor preparation
For H2O2 sensor preparation a pair of 1 mm Pt (Pt/Ir) (90%/10%)
wire (125 mm bare diameter, 175 mm coated diameter (5T);
Advent ResearchMaterials, Suffolk, UK) cylinder electrodes (Ptc)
were modied by a procedure described elsewhere in extensive
detail.37–39 Briey, two polymer modied (Naon® and PPD) Ptc
amperometric electrodes were prepared, one with catalase
adhered (CONTROL) and the other without (PEROX). The H2O2
sensitivity of this biosensor design was derived by subtracting
the CONTROL sensor current response from that recorded at
the PEROX sensor.
Data acquisition and statistical analysis
As previously stated the H2O2 sensitivity of the paired biosensor
design is derived by subtracting the CONTROL sensor current
response from that recorded at the PEROX sensor. The overall
subtracted response of the paired H2O2 sensor has previously
been provided in extensive detail.39
For each change in experimental parameter presented
herein the overall paired subtracted current response of the
H2O2 sensor is discussed (IPEROX  ICONTROL) unless stated
otherwise.
All averaged data is represented as a mean  standard error,
n refers to the number of determinations (perfusions, i.e. repeat
determinations) followed by the number of subjects/sensors. All
analysis was performed using the commercial package Prism
(version 6; GraphPad Soware, Inc., CA, USA). Two-tailed
unpaired or paired t-tests (stated in text) and one-way ANOVAs
with Bonferroni's post hoc test were performed where appro-
priate (specied in text). All statistical analysis was performed
using Prism and values of P < 0.05 were considered to indicate
statistical signicance.
Instrumentation and soware
In vitro calibrations were performed (H2O2: 0–550 mM; AA 0–
1000 mM) in a standard three-electrode glass electrochemical
cell containing 20mL PBS solution as per a previously described
procedure.38 A saturated calomel electrode (SCE) was used as
the reference electrode, and a Pt wire served as the auxiliary
electrode. Constant potential amperometry (CPA; +700 mV) was
utilised without exception for all electrochemical experiments
in vivo/in vitro using a low-noise potentiostat (4 channel Biostat,
ACM instruments, UK). Data acquisition was performed with
either a notebook PC (in vitro) or Mac® (in vivo), a PowerLab
interface system (ADInstruments Ltd, Oxford, UK) and Lab-
Chart® for Windows andMac® (Version 6, ADInstruments Ltd).Anal. Methods, 2017, 9, 1253–1264 | 1261
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View Article OnlineSurgical protocol
Combined MD probe/dual H2O2 sensors were implanted in the
le/right striatum (randomised) as per a modied version of
a previously described procedure.21 The precise surgical
protocol used in the experiments listed here, is described in
detail and provided separately here as ESI.†
Briey, each working electrode (i.e. PEROX and CONTROL)
was positioned accurately, with the use of a microscope, at
either side of an MD probe (MD-2200, 510 mM cannula diameter
BASi, West Lafayette, IN, USA). A total of two working electrodes
(i.e. one PEROX electrode and one CONTROL electrode) were
xed in place on each individual MD probe. A more thorough
description of the MD probe/dual H2O2 sensor construct is
provided as ESI.†
Animals were anaesthetised using isourane (4% in air for
induction, 1.5–3.0% for maintenance; IsoFlo®, Abbott, U.K.)
and placed in a stereotaxic frame (Kopf) and kept on a heating
pad during the surgical procedure to prevent hyperthermia. The
specic coordinates for implantation with the skull levelled
between bregma and lambda were as follows; A/P (1.0 mm), M/L
(2.5 mm) from bregma and D/V (5 mm) from dura. Further
verication of striatal MD probe/sensor implantation was
facilitated by post mortem examination of brain tissue.
A reference electrode and auxiliary electrode were con-
structed in-house (200 mm bare diameter, 270 mm coated
diameter (8T), Advent Research Materials, Suffolk, UK). The
reference electrode was placed in the cortex and the auxiliary
electrode was attached to a surgical support screw as has re-
ported previously21 and further described here as ESI.† The
potential of the reference electrode utilised in vivo is compa-
rable to that seen by the SCE used in in vitro experiments.21
The electrode/MD probe construct was xed in place using
surgical screws (Fine Science Tools GmbH) and dental cement
(Dentalon®, Heraeus-Kulzer, Germany). The animal was removed
from the stereotaxic frame and placed in an incubator (27 C)
until fully recovered. Post-operative analgesia was provided in the
form of an injection (1 mL kg1, s.c.) of Buprecare® (AnimalCare
Ltd, UK) which was administered aer recovery from surgery. The
subject was then closely monitored and le to recover for several
hours in a thermostatically controlled cage (Thermacage MkII,
Datesand Limited, Manchester, UK).
Animals were allowed to recuperate for a minimum of 24 h
following surgery prior to connection with experimental
instrumentation. Subjects were assessed for good health
according to published guidelines immediately aer recovery
from anaesthesia and prior to the commencement of experi-
mental procedures each day. All experiments conducted on
animals were approved by Maynooth University research ethics
committee and performed under license (B100/2205) in accor-
dance with the European Communities Regulations 2002 (Irish
Statutory Instrument 566/2002 Amendment of Cruelty to
Animals Act 1876).Experimental conditions in vivo
Male Wistar rats (Charles River UK Ltd., Kent, UK) weighing
between 200 and 300 g were singly housed using Raturn®1262 | Anal. Methods, 2017, 9, 1253–1264sampling cage systems (BASi, West Lafayette, IN, USA) in
a temperature (17–23 C), humidity and light-controlled (12 h
light/12 h dark; lights on at 07:00) environment with access to
food and water ad libitum. All experiments were carried out with
the animal in its home bowl. The implanted sensors were
connected directly to the potentiostat (4 channel Biostat, ACM
instruments, UK) via a six-pin Teon® socket (Plastics-One,
Roanoke, VA, USA) using a exible screened six-core cable
(Plastics-One, Roanoke, VA, USA). This arrangement allowed
free movement of the animal which remained continuously
connected to the instrumentation. Aer application of the
appropriate applied potential each animal was given a further
24 h before experiments were commenced in order to ensure
that the background currents for the electrodes were completely
stabilised. A low-pass digital lter (50 Hz cut-off) was used to
eliminate mains AC noise and all data was recorded at either 4
or 10 Hz. A Univentor 801 syringe pump was used for perfusion
of substances through the implanted MD probe.Local administrations
All local administrations were delivered to the striatum using
the RD method.41 Substances of interest were perfused through
the MD probe in vivo for a period of approximately 15 minutes
(freely-moving subjects) and 10 minutes (anaesthetised
subjects) at a rate of 2.0 mL min1.Funding
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